Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has dropped 2.6%, driven by Bright Minds Biosciences declining 18%. In contrast, Defence Therapeutics has gained 42%. This takes the industry's 12 month performance to a gain of 8.6%. As for the next few years, earnings are forecast to decline by 4.8% per annum.
Has the Canadian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 21 Feb 2025 | CA$1.6b | CA$85.1m | -CA$318,013,201.74 | 34.1x | -5.2x | 19.3x |
Sun, 19 Jan 2025 | CA$1.6b | CA$87.6m | -CA$319,006,141.30 | 24.7x | -4.9x | 17.8x |
Tue, 17 Dec 2024 | CA$1.5b | CA$83.5m | -CA$311,544,039.89 | 9.6x | -4.8x | 17.9x |
Thu, 14 Nov 2024 | CA$1.3b | CA$80.5m | -CA$276,696,964.98 | 8.3x | -4.8x | 16.6x |
Sat, 12 Oct 2024 | CA$1.1b | CA$80.3m | -CA$279,757,941.59 | 9x | -3.8x | 13.3x |
Mon, 09 Sep 2024 | CA$950.1m | CA$80.3m | -CA$282,092,243.11 | 10.1x | -3.4x | 11.8x |
Wed, 07 Aug 2024 | CA$1.1b | CA$76.2m | -CA$333,080,084.52 | 11.1x | -3.3x | 14.6x |
Fri, 05 Jul 2024 | CA$1.1b | CA$76.8m | -CA$349,903,497.37 | 10.3x | -3.2x | 14.6x |
Sun, 02 Jun 2024 | CA$1.3b | CA$76.8m | -CA$358,960,866.34 | 10.8x | -3.5x | 16.3x |
Tue, 30 Apr 2024 | CA$935.1m | CA$79.4m | -CA$300,976,987.02 | 12.2x | -3.1x | 11.8x |
Thu, 28 Mar 2024 | CA$1.1b | CA$88.5m | -CA$314,723,385.32 | 11.6x | -3.5x | 12.5x |
Sat, 24 Feb 2024 | CA$1.2b | CA$93.1m | -CA$320,866,845.57 | 12.6x | -3.7x | 12.6x |
Mon, 22 Jan 2024 | CA$3.6b | CA$86.3m | -CA$516,461,652.00 | 6.5x | -6.9x | 41.2x |
Wed, 20 Dec 2023 | CA$3.6b | CA$86.3m | -CA$524,954,347.00 | 6.6x | -6.8x | 41.6x |
Fri, 17 Nov 2023 | CA$3.8b | CA$86.7m | -CA$545,156,522.00 | 5.7x | -7x | 44.2x |
Sun, 15 Oct 2023 | CA$3.8b | CA$88.9m | -CA$532,184,232.00 | 5.4x | -7.2x | 42.9x |
Tue, 12 Sep 2023 | CA$4.0b | CA$87.3m | -CA$506,631,558.00 | 5.9x | -7.8x | 45.4x |
Thu, 10 Aug 2023 | CA$4.0b | CA$82.0m | -CA$517,139,152.00 | 6.7x | -7.7x | 48.8x |
Sat, 08 Jul 2023 | CA$4.1b | CA$81.6m | -CA$517,326,691.00 | 13.1x | -7.9x | 50.1x |
Mon, 05 Jun 2023 | CA$3.9b | CA$86.5m | -CA$553,969,079.00 | 13.3x | -7.1x | 45.3x |
Wed, 03 May 2023 | CA$3.8b | CA$82.5m | -CA$586,485,920.00 | 12.6x | -6.5x | 46.5x |
Fri, 31 Mar 2023 | CA$2.5b | CA$91.3m | -CA$605,740,498.00 | 9.8x | -4.1x | 26.9x |
Sun, 26 Feb 2023 | CA$2.8b | CA$90.5m | -CA$598,145,714.00 | 8.6x | -4.8x | 31.4x |
Tue, 24 Jan 2023 | CA$3.2b | CA$87.4m | -CA$524,973,625.00 | 11.7x | -6.1x | 36.8x |
Thu, 22 Dec 2022 | CA$3.0b | CA$88.9m | -CA$533,306,518.00 | 10x | -5.7x | 34.2x |
Sat, 19 Nov 2022 | CA$3.1b | CA$88.1m | -CA$567,652,984.00 | 13.5x | -5.5x | 35.2x |
Mon, 17 Oct 2022 | CA$3.1b | CA$86.2m | -CA$553,217,324.00 | 14.8x | -5.7x | 36.3x |
Wed, 14 Sep 2022 | CA$3.5b | CA$84.5m | -CA$535,355,463.00 | 13.5x | -6.6x | 41.9x |
Fri, 12 Aug 2022 | CA$3.5b | CA$84.9m | -CA$560,423,073.00 | 9.7x | -6.3x | 41.4x |
Sun, 10 Jul 2022 | CA$3.5b | CA$181.8m | -CA$606,427,901.00 | 11.3x | -5.7x | 19.1x |
Tue, 07 Jun 2022 | CA$3.2b | CA$177.8m | -CA$589,750,188.00 | 13.8x | -5.4x | 18x |
Thu, 05 May 2022 | CA$3.4b | CA$181.5m | -CA$480,135,292.00 | 13.4x | -7.1x | 18.7x |
Sat, 02 Apr 2022 | CA$3.5b | CA$171.6m | -CA$490,730,178.00 | 15.3x | -7x | 20.2x |
Mon, 28 Feb 2022 | CA$3.3b | CA$167.5m | -CA$469,954,080.00 | 15.6x | -7.1x | 19.8x |
-7.1x
Which industries have driven the changes within the Canadian Healthcare industry?
CA Market | -0.52% | |
Healthcare | -1.70% | |
Biotech | -3.80% | |
Biotech | -3.80% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MDCX Medicus Pharma | CA$5.70 | 46.2% +CA$21.1m | 9.6% | n/a | |
TH Theratechnologies | CA$2.72 | 17.7% +CA$18.9m | 25.9% | PS1x | |
DTC Defence Therapeutics | CA$1.53 | 31.9% +CA$17.8m | -22.3% | PE-6.4x | |
EPRX Eupraxia Pharmaceuticals | CA$5.06 | 10.5% +CA$17.1m | -29.1% | PB13.4x | |
GLAB Gemina Laboratories | CA$0.80 | 33.3% +CA$14.9m | 42.9% | PE-17.5x |